Genomic Landscape of Esophageal Squamous Cell Carcinoma in a Japanese Population

Gastroenterology

Volumn 150, Issue 5, 2016, Pages 1171-1182

  Sawada, Genta ^a,b   Niida, Atsushi ^c   Uchi, Ryutaro ^a   Hirata, Hidenari ^a   Shimamura, Teppei ^c   Suzuki, Yutaka ^c   Shiraishi, Yuichi ^c   Chiba, Kenichi ^c   Imoto, Seiya ^c   Takahashi, Yusuke ^a,b   Iwaya, Takeshi ^d   Sudo, Tomoya ^a   Hayashi, Tomoatsu ^c   Takai, Hiroki ^c   Kawasaki, Yoshihiro ^c   Matsukawa, Takashi ^c   Eguchi, Hidetoshi ^a   Sugimachi, Keishi ^a   Tanaka, Fumiaki ^a   Suzuki, Hiromichi ^e   Yamamoto, Ken ^f   Ishii, Hideshi ^b   Shimizu, Makiko ^g   Yamazaki, Hiroshi ^g   Yamazaki, Makoto ^b   Tachimori, Yuji ^h   Kajiyama, Yoshiaki ⁱ   Natsugoe, Shoji ^j   Fujita, Hiromasa ^f   Mafune, Kenichi ^k   Tanaka, Yoichi ^l   Kelsell, David P ^m   Scott, Claire A ^m   Tsuji, Shoji ^c   Yachida, Shinichi ⁿ   Shibata, Tatsuhiro ^c,n   Sugano, Sumio ^c   Doki, Yuichiro ^b   Akiyama, Tetsu ^c   Aburatani, Hiroyuki ^o   Ogawa, Seishi ^e   Miyano, Satoru ^c   Mori, Masaki ^b   Mimori, Koshi ^a   more..

^a KYUSHU UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d IWATE MEDICAL UNIVERSITY   (Japan)

^e KYOTO UNIVERSITY   (Japan)

^f KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^h NATIONAL CANCER CENTER HOSPITAL   (Japan)

ⁱ JUNTENDO UNIVERSITY   (Japan)

^j KAGOSHIMA UNIVERSITY   (Japan)

^k Mitsui Kinen Hospital   (Japan)

^l SAITAMA CANCER CENTER   (Japan)

^m QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

ⁿ NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^o UNIVERSITY OF TOKYO   (Japan)

more..

Author keywords

Copy Number Profiling; Esophagus; Exome Sequencing; Mutational Signature

Indexed keywords

5 HYDROXYMETHYLCYTOSINE; CYTOCHROME P450 2A6; PHOSPHATIDYLINOSITIDE; PROTEIN TYROSINE KINASE; THYMINE; ADH1B PROTEIN, HUMAN; ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; ALDH2 PROTEIN, HUMAN; CYP2A6 PROTEIN, HUMAN; TUMOR MARKER;

ALCOHOL CONSUMPTION; ARTICLE; CELL CYCLE; CHROMOSOME; CPG ISLAND; ENVIRONMENTAL FACTOR; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGEAL TISSUE; GENE MUTATION; GENETIC RISK; GENOMICS; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; HUMAN CELL; HUMAN TISSUE; JAPAN; JAPANESE (PEOPLE); MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; SURVIVAL TIME; TRANSCRIPTION INITIATION; ASIAN CONTINENTAL ANCESTRY GROUP; CLINICAL TRIAL; DNA MICROARRAY; DNA MUTATIONAL ANALYSIS; EPIDEMIOLOGY; ESOPHAGUS TUMOR; ETHNOLOGY; EXOME; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; METABOLISM; MULTICENTER STUDY; MUTATION; PATHOLOGY; PHENOTYPE; PROCEDURES; SQUAMOUS CELL CARCINOMA;

ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE, MITOCHONDRIAL; ASIAN CONTINENTAL ANCESTRY GROUP; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CPG ISLANDS; CYTOCHROME P-450 CYP2A6; DNA MUTATIONAL ANALYSIS; ESOPHAGEAL NEOPLASMS; EXOME; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE-ENVIRONMENT INTERACTION; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HEK293 CELLS; HUMANS; JAPAN; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TRANSFECTION;

EID: 84964343756     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.01.035     Document Type: Article

References (43)

1. P.C. Enzinger, and R.J. Mayer Esophageal cancer N Engl J Med 349 2003 2241 2252
2. H. Shimada, H. Kitabayashi, Y. Nabeya, and et al. Treatment response and prognosis of patients after recurrence of esophageal cancer Surgery 133 2003 24 31
3. Y. Lin, Y. Totsuka, Y. He, and et al. Epidemiology of esophageal cancer in Japan and China J Epidemiol 23 2013 233 242
4. F. Tanaka, K. Yamamoto, S. Suzuki, and et al. Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles Gut 59 2010 1457 1464
5. R. Cui, Y. Kamatani, A. Takahashi, and et al. Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk Gastroenterology 137 2009 1768 1775
6. Y. Gao, N. Hu, X. Han, and et al. Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China BMC Cancer 9 2009 269
7. G.D. Tran, X.D. Sun, C.C. Abnet, and et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China Int J Cancer 113 2005 456 463
8. Y. Yokokawa, S. Ohta, J. Hou, and et al. Ecological study on the risks of esophageal cancer in Ci-Xian, China: the importance of nutritional status and the use of well water Int J Cancer 83 1999 620 624
9. N. Agrawal, Y. Jiao, C. Bettegowda, and et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma Cancer Discov 2 2012 899 905
10. D.C. Lin, J.J. Hao, Y. Nagata, and et al. Genomic and molecular characterization of esophageal squamous cell carcinoma Nat Genet 46 2014 467 473
11. Y.B. Gao, Z.L. Chen, J.G. Li, and et al. Genetic landscape of esophageal squamous cell carcinoma Nat Genet 46 2014 1097 1102
12. Y. Song, L. Li, Y. Ou, and et al. Identification of genomic alterations in oesophageal squamous cell cancer Nature 509 2014 91 95
13. L. Zhang, Y. Zhou, C. Cheng, and et al. Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma Am J Hum Genet 96 2015 597 611
14. Y. Shiraishi, Y. Sato, K. Chiba, and et al. An empirical Bayesian framework for somatic mutation detection from cancer genome sequencing data Nucleic Acids Res 41 2013 e89
15. P. Van Loo, S.H. Nordgard, O.C. Lingjaerde, and et al. Allele-specific copy number analysis of tumors Proc Natl Acad Sci U S A 107 2010 16910 16915
16. L.B. Alexandrov, S. Nik-Zainal, D.C. Wedge, and et al. Signatures of mutational processes in human cancer Nature 500 2013 415 421
17. S.A. Roberts, M.S. Lawrence, L.J. Klimczak, and et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers Nat Genet 45 2013 970 976
18. Comprehensive genomic characterization of head and neck squamous cell carcinomas Nature 517 2015 576 582
19. Comprehensive genomic characterization of squamous cell lung cancers Nature 489 2012 519 525
20. A.M. Dulak, P. Stojanov, S. Peng, and et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity Nat Genet 45 2013 478 486
21. M. Fujieda, H. Yamazaki, T. Saito, and et al. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers Carcinogenesis 25 2004 2451 2458
22. A. Niida, S. Imoto, T. Shimamura, and et al. Statistical model-based testing to evaluate the recurrence of genomic aberrations Bioinformatics 28 2012 i115 i120
23. K. Wang, S.T. Yuen, J. Xu, and et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer Nat Genet 46 2014 573 582
24. G.L. Sen, L.D. Boxer, D.E. Webster, and et al. ZNF750 is a p63 target gene that induces KLF4 to drive terminal epidermal differentiation Dev Cell 22 2012 669 677
25. G.I. Evan, and K.H. Vousden Proliferation, cell cycle and apoptosis in cancer Nature 411 2001 342 348
26. H. Shen, and P.W. Laird Interplay between the cancer genome and epigenome Cell 153 2013 38 55
27. B. Schuettengruber, A.M. Martinez, N. Iovino, and et al. Trithorax group proteins: switching genes on and keeping them active Nat Rev Mol Cell Biol 12 2011 799 814
28. E. Solary, O.A. Bernard, A. Tefferi, and et al. The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases Leukemia 28 2014 485 496
29. Y. Sato, T. Yoshizato, Y. Shiraishi, and et al. Integrated molecular analysis of clear-cell renal cell carcinoma Nat Genet 45 2013 860 867
30. S. Seshagiri, E.W. Stawiski, S. Durinck, and et al. Recurrent R-spondin fusions in colon cancer Nature 488 2012 660 664
31. T. Shibata, T. Ohta, K.I. Tong, and et al. Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy Proc Natl Acad Sci U S A 105 2008 13568 13573
32. Y.R. Kim, J.E. Oh, M.S. Kim, and et al. Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin J Pathol 220 2010 446 451
33. M.B. Sporn, and K.T. Liby NRF2 and cancer: the good, the bad and the importance of context Nat Rev Cancer 12 2012 564 571
34. D. Malhotra, E. Portales-Casamar, A. Singh, and et al. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis Nucleic Acids Res 38 2010 5718 5734
35. A. Niida, A.D. Smith, S. Imoto, and et al. Gene set-based module discovery in the breast cancer transcriptome BMC Bioinformatics 10 2009 71
36. P. Ntziachristos, J.S. Lim, J. Sage, and et al. From fly wings to targeted cancer therapies: a centennial for notch signaling Cancer Cell 25 2014 318 334
37. N.E. Hynes, and H.A. Lane ERBB receptors and cancer: the complexity of targeted inhibitors Nat Rev Cancer 5 2005 341 354
38. L.M. Thorpe, H. Yuzugullu, and J.J. Zhao PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting Nat Rev Cancer 15 2015 7 24
39. L.G. Morris, A.M. Kaufman, Y. Gong, and et al. Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation Nat Genet 45 2013 253 261
40. K. Haraguchi, M. Ohsugi, Y. Abe, and et al. Ajuba negatively regulates the Wnt signaling pathway by promoting GSK-3beta-mediated phosphorylation of beta-catenin Oncogene 27 2008 274 284
41. J. Rosenbluh, D. Nijhawan, A.G. Cox, and et al. beta-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis Cell 151 2012 1457 1473
42. C.H. Hsu, K.L. Peng, M.L. Kang, and et al. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases Cell Rep 2 2012 568 579
43. T. Shibata, A. Kokubu, S. Saito, and et al. NRF2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer Neoplasia 13 2011 864 873